{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"TB:  Point-of-Care. Precision. Progress. \ud83d\udccd\ud83e\udde0\ud83d\udcc8","description":"A quiet revolution in tuberculosis diagnostics is here. \ud83e\uddea\ud83c\udf0d &amp;nbsp; This NEJM study shows that MiniDock MTB, a rapid swab-based molecular test, delivers Xpert-level accuracy with minimal training and no adverse events\u2014all in a near\u2013point-of-care format. \u23f1\ufe0f\ud83e\udde0 &amp;nbsp; Key insights: \ud83d\udd39 Sensitivity: 85.7% (sputum), 79.6% (tongue) \ud83d\udd39 Specificity: &amp;gt;97\u201399% \ud83d\udd39 Strong performance vs smear microscopy (+24% sensitivity) \ud83d\udd39 Usability score: 75\u2014ready for real-world deployment &amp;nbsp; The implications are profound: \ud83d\udc49 Noninvasive testing for patients unable to produce sputum \ud83d\udc49 Decentralized diagnostics in resource-limited settings \ud83d\udc49 A realistic path to closing the global TB detection gap &amp;nbsp; From central labs to community clinics\u2014this is how access scales. \ud83d\ude80 &amp;nbsp; \ud83d\udcd6 Yerlikaya et al., NEJM 2026 &amp;nbsp; #Tuberculosis #GlobalHealth #Diagnostics #PointOfCare #PublicHealth #InfectiousDiseases #PrecisionMedicine #MedicalInnovation #HealthEquity #TBElimination ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41070715\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/201341900"}